Los Angeles Capital Management
OLMA icon

Los Angeles Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

Los Angeles Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$148K Buy
11,834
+11,180
+1,709% +$150K ﹤0.01% 1245
2026
Q1 		$9.75K Sell
654
-37,424
-98% -$833K ﹤0.01% 1959
2025
Q4 		$334K Buy
+38,078
New +$678K ﹤0.01% 1044

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Los Angeles Capital Management's OLMA Position: Q2 2026 in Review

Los Angeles Capital Management increased its Olema Pharmaceuticals (OLMA) stake by 1,709% in Q2 2026, buying an estimated $150K and bringing the position to 11,834 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #1245.

Los Angeles Capital Management first reported a position in OLMA in Q4 2025 and has held it in 3 quarters since. The position peaked at $334K in Q4 2025. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Los Angeles Capital Management held 11,834 shares of Olema Pharmaceuticals worth $148K as of Q2 2026.
  • Los Angeles Capital Management bought 11,180 Olema Pharmaceuticals shares in Q2 2026, an estimated $150K.
  • Olema Pharmaceuticals made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #1245 holding.
  • Los Angeles Capital Management first reported a position in Olema Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Los Angeles Capital Management's Olema Pharmaceuticals position peaked at $334K in Q4 2025.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.